Direct measurement of insulin resistance is difficult and therefore in order to help clinicians identify persons who might be insulin resistant a clinically defined entity - the metabolic syndrome - was first proposed by the World Health Organization (WHO) [3]. This evidence concerns the gene INS and Insulin resistance.